Therapeutic Development Data

Member Proposal Form

Research Data Requirements

GLP-1

  • Semaglutide (Ozempic, Rybelsus, Wegovy)
  • Dulaglutide (Trulicity)
  • Exenatide extended release (Bydureon BCise)
  • Exenatide (Byetta)
  • Liraglutide (Victoza, Saxenda)
  • Lixisenatide (Adlyxin)
  • Age: 18+
  • Gender: All genders
  • Diagnosis: All diagnoses
  • Treatment: Prescribed a GLP-1 receptor agonist 
  • Observation Period: 12 months prior to initiation of GLP-1 treatment through 1/1/2025

Anonymized data set containing in CSV, excel or SQL formats.

Data fields per item required:

  • Patient Table: Includes all patients satisfying the cohort requirements.
  • Condition Table: Includes all diagnoses associated with cohort members during the observation period
  • Procedure Table: Includes all procedures associated with cohort members during the observation period
  • Treatment Table: Includes all medications (semaglutide and all other drugs) associated with cohort members during the observation period
  • Measurement Table: Includes all laboratory tests associated with cohort members during the observation period
To participate in this project, please provide the information here below and a member of our ResearchNexo© team will contact within the next business day
Notice: DO NOT include any personalized information, including but not limited to name for a patient, patient identification or other data that can enables identification of an individual patient.

Enter Your Proposal Details Here!